About Us

olive

DEVOTED TO NATURAL INGREDIENTS

Founded in 2009, our goal was (and continues to be) to develop products based on key elements of the Mediterranean diet in combination with other natural ingredients that have been shown to support the body’s fight against inflammation.

The healthy effect of olive oil, a key element of the Mediterranean diet, has been extensively studied over the last several decades; many believe that olive oil polyphenols are one of the principal drivers of the health benefits typically attributed to the diet.

Our PureVida® and OliPura® line of products all incorporate a proprietary olive oil polyphenol extract, TrePhenol®, developed and clinically evaluated by Oliventures and its partners in Spain.

Mediterranean Diet Pyramid
olives on desk

TREPHENOL® IS OLIVENTURES’ FOUNDATIONAL INGREDIENT

TrePhenol® olive fruit extract is Oliventures’ tested blend of 2 of the most extensively studied polyphenols in olive oil: hydroxytyrosol and tyrosol.

TrePhenol® is:

  • 100% natural
  • Chemical- and pesticide-free
  • Extracted from high-quality Spanish olives that are non-GMO (non-genetically modified organisms)
  • Made using patented clean technology and recovered with water

In laboratory trials sponsored by Oliventures and conducted under the direction of its Duke University medical advisors, TrePhenol® demonstrated anti-inflammatory characteristics that are consistent with extensive third-party scientific studies, conducted over the last several decades, that point to the potential health benefits of olive polyphenols. Results of Oliventures’ preclinical trials as well as references to the landmark PREDIMED study, covering over 7,000 patients, are available for your health care provider to review here.

In addition to TrePhenol, Oliventures incorporates other high-quality ingredients in our nutritional supplements including:

  • Marine Omega-3s: Sourced from a single-species, sustainably caught and refined in the U.S. fish oil. Omega-3s are another key element of the Mediterranean diet.
  • Turmeric Curcumin: High-purity, sourced from the Turmeric root.

Table below indicates the amount of ingredients/serving.

Product TrePhenol® Olive Polyphenols Marine Omega-3s Turmeric Curcumin
PureVida 375 mg 43.1 mg 750 mg 120 mg
OliPura Heart 187.5 mg 32.3 mg 1,000 mg
OliPura Joint 375 mg 64.5 mg 175 mg
OliPura Daily Living 300 mg 51.6 mg
OliPura Rx 600 mg 103.2 mg

Oliventures uses varying strengths of TrePhenol® in its formulations.

Dr. Michael Morse, Oliventures’ Chief Medical Officer, in conjunction with a medical team in Spain, developed the formulation for PureVida based on the Company’s preclinical research on TrePhenol® and third-party evidence as to the potential benefits of coupling TrePhenol® with marine omega-3s and high-purity curcumin. The team believes that the formulation has the potential to support the body’s response to inflammation. The clinical trial conducted by Oliventures in Spain (with 45 patients) sought to demonstrate that the unique combination of natural ingredients in PureVida can lower C-reactive protein (CRP) levels. CRP is a marker of inflammation produced by the liver and other organs in response to the release of certain pro-inflammatory substances by immune cells following injury or infection and other conditions associated with tissue injury and inflammation. The trial results demonstrated reduced levels of CRP and a reduction in joint pain in women taking aromatase inhibitors. Because only one trial, with 45 participants, has been performed (and the results have not yet been peer reviewed), more research is needed to confirm that the results of the one trial are valid.a

SCIENTIFIC ADVISORS

Michael A. Morse

Professor of Medicine, Professor in the Department of Surgery

Member of the Duke Cancer Institute, Duke University, Raleigh, NC

Research expertise includes the development of targeted therapies, including immunotherapies for solid tumors. He is an Associate Editor for the journal Clinical Cancer Research and has been the principal investigator for a number of Phase 1 and 2 clinical trials.

luis-madero

Head of Oncohematology, University Hospital Niño Jesus, Madrid, Spain

Professor at Universidad Autónoma, Madrid, Spain

President, Asociación Española de Pediatría (Spanish Association of Pediatrics)

Member of the National Academy of Medicine. Performed the first cord blood transplant in Spain. Head of several national medical advisory committees. Extensively published in multiple scientific journals and is author of several medical texts.

francesco-visioli

Senior Investigator, Madrid Institute for Advanced Studies (IMDEA)-Food

Editor in Chief, PharmaNutrition University of Padova, Padova, Italy

Member of the European Food Safety Association (EFSA) expert panel.

Discovered biologic and pharmacologic properties of phenols in olive oil. He has published more than 190 scientific articles and has been cited more than 5200 times (H-index=42).